1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Pre-renal 1.2.3 Intrinsic-renal 1.2.4 Post-renal 1.3 Market by Application 1.3.1 Global ICU-acquired Acute Kidney Treatment Market Share by Application: 2020 VS 2026 1.3.2 Public Hospital 1.3.3 Private Hospital 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global ICU-acquired Acute Kidney Treatment Market Perspective (2015-2026) 2.2 Global ICU-acquired Acute Kidney Treatment Growth Trends by Regions 2.2.1 ICU-acquired Acute Kidney Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 ICU-acquired Acute Kidney Treatment Historic Market Share by Regions (2015-2020) 2.2.3 ICU-acquired Acute Kidney Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top ICU-acquired Acute Kidney Treatment Players by Market Size 3.1.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue (2015-2020) 3.1.2 Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Players (2015-2020) 3.2 Global ICU-acquired Acute Kidney Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by ICU-acquired Acute Kidney Treatment Revenue 3.4 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio 3.4.1 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by ICU-acquired Acute Kidney Treatment Revenue in 2019 3.5 Key Players ICU-acquired Acute Kidney Treatment Area Served 3.6 Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service 3.7 Date of Enter into ICU-acquired Acute Kidney Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 ICU-acquired Acute Kidney Treatment Breakdown Data by Type (2015-2026) 4.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Type (2015-2020) 4.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2021-2026) 5 ICU-acquired Acute Kidney Treatment Breakdown Data by Application (2015-2026) 5.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Application (2015-2020) 5.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America ICU-acquired Acute Kidney Treatment Market Size (2015-2026) 6.2 North America ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) 6.3 North America ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) 6.4 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe ICU-acquired Acute Kidney Treatment Market Size (2015-2026) 7.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) 7.3 Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) 7.4 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China ICU-acquired Acute Kidney Treatment Market Size (2015-2026) 8.2 China ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) 8.3 China ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) 8.4 China ICU-acquired Acute Kidney Treatment Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan ICU-acquired Acute Kidney Treatment Market Size (2015-2026) 9.2 Japan ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) 9.3 Japan ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) 9.4 Japan ICU-acquired Acute Kidney Treatment Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia ICU-acquired Acute Kidney Treatment Market Size (2015-2026) 10.2 Southeast Asia ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) 10.3 Southeast Asia ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) 10.4 Southeast Asia ICU-acquired Acute Kidney Treatment Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Quark Pharmaceuticals 11.1.1 Quark Pharmaceuticals Company Details 11.1.2 Quark Pharmaceuticals Business Overview 11.1.3 Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Introduction 11.1.4 Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020)) 11.1.5 Quark Pharmaceuticals Recent Development 11.2 Fresenius Medical Care 11.2.1 Fresenius Medical Care Company Details 11.2.2 Fresenius Medical Care Business Overview 11.2.3 Fresenius Medical Care ICU-acquired Acute Kidney Treatment Introduction 11.2.4 Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) 11.2.5 Fresenius Medical Care Recent Development 11.3 B. Braun 11.3.1 B. Braun Company Details 11.3.2 B. Braun Business Overview 11.3.3 B. Braun ICU-acquired Acute Kidney Treatment Introduction 11.3.4 B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) 11.3.5 B. Braun Recent Development 11.4 Baxter international 11.4.1 Baxter international Company Details 11.4.2 Baxter international Business Overview 11.4.3 Baxter international ICU-acquired Acute Kidney Treatment Introduction 11.4.4 Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) 11.4.5 Baxter international Recent Development 11.5 Angion Biomedica Corp 11.5.1 Angion Biomedica Corp Company Details 11.5.2 Angion Biomedica Corp Business Overview 11.5.3 Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Introduction 11.5.4 Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) 11.5.5 Angion Biomedica Corp Recent Development 11.6 Asahi Kasei Medical 11.6.1 Asahi Kasei Medical Company Details 11.6.2 Asahi Kasei Medical Business Overview 11.6.3 Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Introduction 11.6.4 Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) 11.6.5 Asahi Kasei Medical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Pre-renal Table 4. Key Players of Intrinsic-renal Table 5. Key Players of Post-renal Table 6. Global ICU-acquired Acute Kidney Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 7. Global ICU-acquired Acute Kidney Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 8. Global ICU-acquired Acute Kidney Treatment Market Size by Regions (2015-2020) (US$ Million) Table 9. Global ICU-acquired Acute Kidney Treatment Market Share by Regions (2015-2020) Table 10. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 11. Global ICU-acquired Acute Kidney Treatment Market Share by Regions (2021-2026) Table 12. ICU-acquired Acute Kidney Treatment Market Market Trends Table 13. ICU-acquired Acute Kidney Treatment Market Drivers Table 14. ICU-acquired Acute Kidney Treatment Market Challenges Table 15. ICU-acquired Acute Kidney Treatment Market Restraints Table 16. Global ICU-acquired Acute Kidney Treatment Revenue by Players (2015-2020) (US$ Million) Table 17. Global ICU-acquired Acute Kidney Treatment Market Share by Players (2015-2020) Table 18. Global Top ICU-acquired Acute Kidney Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2019) Table 19. Global ICU-acquired Acute Kidney Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 20. Key Players Headquarters and Area Served Table 21. Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) (US$ Million) Table 24. Global ICU-acquired Acute Kidney Treatment Market Size Share by Type (2015-2020) Table 25. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2021-2026) Table 26. Global ICU-acquired Acute Kidney Treatment Market Size Share by Application (2015-2020) Table 27. Global ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) (US$ Million) Table 28. Global ICU-acquired Acute Kidney Treatment Market Size Share by Application (2021-2026) Table 29. North America ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) (US$ Million) Table 30. North America ICU-acquired Acute Kidney Treatment Market Share by Type (2015-2020) Table 31. North America ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) (US$ Million) Table 32. North America ICU-acquired Acute Kidney Treatment Market Share by Application (2015-2020) Table 33. North America ICU-acquired Acute Kidney Treatment Market Size by Country (US$ Million) (2015-2020) Table 34. North America ICU-acquired Acute Kidney Treatment Market Share by Country (2015-2020) Table 35. Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) (US$ Million) Table 36. Europe ICU-acquired Acute Kidney Treatment Market Share by Type (2015-2020) Table 37. Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) (US$ Million) Table 38. Europe ICU-acquired Acute Kidney Treatment Market Share by Application (2015-2020) Table 39. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (US$ Million) (2015-2020) Table 40. Europe ICU-acquired Acute Kidney Treatment Market Share by Country (2015-2020) Table 41. China ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) (US$ Million) Table 42. China ICU-acquired Acute Kidney Treatment Market Share by Type (2015-2020) Table 43. China ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) (US$ Million) Table 44. China ICU-acquired Acute Kidney Treatment Market Share by Application (2015-2020) Table 45. China ICU-acquired Acute Kidney Treatment Market Size by Region (US$ Million) (2015-2020) Table 46. China ICU-acquired Acute Kidney Treatment Market Share by Region (2015-2020) Table 47. Japan ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) (US$ Million) Table 48. Japan ICU-acquired Acute Kidney Treatment Market Share by Type (2015-2020) Table 49. Japan ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) (US$ Million) Table 50. Japan ICU-acquired Acute Kidney Treatment Market Share by Application (2015-2020) Table 51. Japan ICU-acquired Acute Kidney Treatment Market Size by Country (US$ Million) (2015-2020) Table 52. Japan ICU-acquired Acute Kidney Treatment Market Share by Country (2015-2020) Table 53. Southeast Asia ICU-acquired Acute Kidney Treatment Market Size by Type (2015-2020) (US$ Million) Table 54. Southeast Asia ICU-acquired Acute Kidney Treatment Market Share by Type (2015-2020) Table 55. Southeast Asia ICU-acquired Acute Kidney Treatment Market Size by Application (2015-2020) (US$ Million) Table 56. Southeast Asia ICU-acquired Acute Kidney Treatment Market Share by Application (2015-2020) Table 57. Southeast Asia ICU-acquired Acute Kidney Treatment Market Size by Country (US$ Million) (2015-2020) Table 58. Southeast Asia ICU-acquired Acute Kidney Treatment Market Share by Country (2015-2020) Table 59. Quark Pharmaceuticals Company Details Table 60. Quark Pharmaceuticals Business Overview Table 61. Quark Pharmaceuticals Product Table 62. Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) (US$ Million) Table 63. Quark Pharmaceuticals Recent Development Table 64. Fresenius Medical Care Company Details Table 65. Fresenius Medical Care Business Overview Table 66. Fresenius Medical Care Product Table 67. Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) (US$ Million) Table 68. Fresenius Medical Care Recent Development Table 69. B. Braun Company Details Table 70. B. Braun Business Overview Table 71. B. Braun Product Table 72. B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) (US$ Million) Table 73. B. Braun Recent Development Table 74. Baxter international Company Details Table 75. Baxter international Business Overview Table 76. Baxter international Product Table 77. Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) (US$ Million) Table 78. Baxter international Recent Development Table 79. Angion Biomedica Corp Company Details Table 80. Angion Biomedica Corp Business Overview Table 81. Angion Biomedica Corp Product Table 82. Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) (US$ Million) Table 83. Angion Biomedica Corp Recent Development Table 84. Asahi Kasei Medical Company Details Table 85. Asahi Kasei Medical Business Overview Table 86. Asahi Kasei Medical Product Table 87. Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2015-2020) (US$ Million) Table 88. Asahi Kasei Medical Recent Development Table 89. Research Programs/Design for This Report Table 90. Key Data Information from Secondary Sources Table 91. Key Data Information from Primary Sources List of Figures Figure 1. Global ICU-acquired Acute Kidney Treatment Market Share by Type: 2020 VS 2026 Figure 2. Pre-renal Features Figure 3. Intrinsic-renal Features Figure 4. Post-renal Features Figure 5. Global ICU-acquired Acute Kidney Treatment Market Share by Application: 2020 VS 2026 Figure 6. Public Hospital Case Studies Figure 7. Private Hospital Case Studies Figure 8. ICU-acquired Acute Kidney Treatment Report Years Considered Figure 9. Global ICU-acquired Acute Kidney Treatment Market Size (US$ Million), YoY Growth 2015-2026 Figure 10. Global ICU-acquired Acute Kidney Treatment Market Share by Regions: 2020 VS 2026 Figure 11. Global ICU-acquired Acute Kidney Treatment Market Share by Regions (2021-2026) Figure 12. Global ICU-acquired Acute Kidney Treatment Market Share by Players in 2019 Figure 13. Global Top ICU-acquired Acute Kidney Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2019 Figure 14. The Top 10 and 5 Players Market Share by ICU-acquired Acute Kidney Treatment Revenue in 2019 Figure 15. North America ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 16. United States ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. Canada ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Europe ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Germany ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. France ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. U.K. ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Italy ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Russia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Nordic ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Rest of Europe ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. China ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Japan ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. South Korea ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Southeast Asia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. India ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Australia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Rest of Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Latin America ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Mexico ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Brazil ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Turkey ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Saudi Arabia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. UAE ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Rest of Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Quark Pharmaceuticals Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2015-2020) Figure 43. Fresenius Medical Care Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2015-2020) Figure 44. B. Braun Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2015-2020) Figure 45. Baxter international Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2015-2020) Figure 46. Angion Biomedica Corp Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2015-2020) Figure 47. Asahi Kasei Medical Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2015-2020) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed

Quark Pharmaceuticals Fresenius Medical Care B. Braun Baxter international Angion Biomedica Corp Asahi Kasei Medical